FDG PET/CT in Aortic Valve Bioprosthesis Infection

Clin Nucl Med. 2017 Jul;42(7):e347-e348. doi: 10.1097/RLU.0000000000001675.

Abstract

A 62-year-old man presented with persistent fever, weakness, and retrosternal pain 3 years after aortic valve bioprosthesis (AVR). His white blood cell count was 11,000/μL and C-reactive protein was 13.6 mg/dL. Consecutive blood cultures isolated Staphylococcus epidermidis and capitis. Transesophageal echocardiography demonstrated small aortic valve prosthesis vegetation. F-FDG PET/CT revealed prominent AVR activity, SUVmax = 12.2. He was treated with daptomycin, meropenem, and gentamicin for 1 month and followed by daptomycin and carbapenem for 3 months. Follow-up F-FDG PET/CT at 6 months demonstrated complete clearing of AVR activity associated with full asymptomatic recovery.

Publication types

  • Case Reports

MeSH terms

  • Aortic Valve*
  • Bioprosthesis / microbiology*
  • Fluorodeoxyglucose F18*
  • Follow-Up Studies
  • Heart Valve Prosthesis / microbiology*
  • Humans
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography*
  • Prosthesis-Related Infections / diagnostic imaging*
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / etiology
  • Prosthesis-Related Infections / microbiology
  • Treatment Outcome

Substances

  • Fluorodeoxyglucose F18